Questions - Cabinet Office Prime minister's questions Ten minute rule motion - health and safety (amendment) Motion - police grants and local government finance reports Adjournment debate - future of stereotactic
body radiotherapy treatment in England
Not exact matches
The NIHR - funded researchers, based at The Royal Marsden hospital in London, asked 42 breast cancer patients undergoing
radiotherapy to rate how they felt about their
body, before the
treatment and one month later.
Steven Landeg, a senior radiographer from the Royal Marsden, who is presenting the data, said: «These findings suggest that offering fluorescent
radiotherapy tattoos as an alternative to dark ink ones could help ameliorate the negative feelings some women feel towards their
bodies after
treatment.
Dr Bernardo Tavora, lead author on the paper from the Barts Cancer Institute, said: «This work shows that sensitivity to cancer
treatment is related to our own
body mistakenly trying to shield the cancer from cell - killing effects caused by
radiotherapy and chemotherapy.
«These patients are too ill to receive any other
treatment, but with stereotactic
body radiotherapy we're able to deliver a safe and effective
treatment in two weeks that can provide them with a substantial quality of life with minimal side effects.»
Called stereotactic
body radiotherapy (SBRT), the study finds patients lived, on average, six to seven months longer following
treatment with minimal side - effects even when they had other severe comorbidities such as chronic obstructive pulmonary disease (COPD), heart disease and diabetes.